Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MicroRNA 3689c is a human gene encoding a microRNA, a small non-coding RNA molecule that acts primarily as a post-transcriptional regulator by binding to complementary sequences in messenger RNA (mRNA), leading to translational inhibition or destabilization of the target mRNA. MicroRNAs are produced from distinct genes and undergo a specialized biogenesis pathway, generating mature 22-nucleotide RNAs that act as components of the RNA-induced silencing complex (RISC). MIR3689C has been linked to vulva squamous cell carcinoma, although its specific role in this or other diseases has not been comprehensively characterized. Like other microRNAs, MIR3689C may participate in complex gene regulatory networks and has relevance to cancer if its expression is dysregulated, but no direct drug targeting or therapeutic applications have been reported for it to date.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MicroRNA 3689c (MIR3689C).